ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers, Inc. (TYMI)
1448.69 -13.07 (-89.41%)  
Open: 45.17 Prev Close: 1461.76
High: 1465.8 Low: 1446.56
Volume: 4,472,564 Market Cap: 701321M
Year High: 1498 Year Low: 833.5
Stock Technical Analysis
Targets Six months: 5.2560    One year: 6.1390
Supports Support1: 3.3443   Support2: 2.6300
Resistances Resistance1: 4.5000    Resistance2: 5.2560 
Pivot Point 3.0267 
Moving Averages MA(5): 3.2000      MA(20): 2.9695 

MA(100): 3.0173  1     MA(250):  
MACD MACD(12,26): 0.101      Signal(12,26,9): -0.005 
Stochastic Oscillator %K(14,3): 59.700      %D(3): 38.125 
RSI RSI(14): 72.987 
52-Week High: 5.2000  Low: 1.0100  Change(%): -23
Average Volume(K) 3-Month: 229  10-Days: 14
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is above its mid-term; and above long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BULLISH in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above the upper band by 13.5%; Bollinger Bands are 88.7% wider than normal.The large width of the bands suggest high volatility as compared to TYMI's normal range. The bands have been in this wide range for 1 bars. This is often a sign that the current trend may be ending.


Stock Chart

Top 100 stocks

Stock News
Tyme Technologies, Inc. (NasdaqCM:TYME) Shareholder Yield & Analysis
Sun, 18 Feb 2018 23:28:20 GMT

Tyme Technologies, Inc. Announces $8.2 Million Private Placement
Wed, 22 Mar 2017 16:07:30 GMT

Tyme Inc. Appoints Dr. Jonathan Eckard as Chief Scientific Affairs Officer
Wed, 09 Aug 2017 12:30:56 GMT

Tyme Technologies, Inc. Announces the Issuance of Two New Platform Patents
Mon, 14 Aug 2017 12:32:36 GMT

Tyme Technologies, Inc. Completes Reverse Merger
Thu, 19 Mar 2015 12:22:30 GMT

Tyme Technologies Inc. (Nasdaq: TYME) to Ring The Nasdaq Stock Market Opening Bell
Mon, 07 Aug 2017 12:22:30 GMT

Tyme Technologies Inc.
Sat, 16 Sep 2017 17:30:19 GMT

Tyme Technologies, Inc. Receives FDA Acceptance of Investigational New Drug ...
Mon, 26 Oct 2015 20:26:15 GMT

Tyme Technologies Presents Positive Interim Clinical Data in Recurrent, Non ...
Mon, 05 Jun 2017 12:56:15 GMT

Tyme Technologies Announces Hiring of Shabnam Stanicky as Clinical Operations ...
Fri, 06 Jan 2017 13:30:00 GMT